Cannabis in Malta: Laws, CBD & Medical Access
Last reviewed: 17 October 2026
Malta has separate rules for personal cannabis use, cannabis harm-reduction associations, medicinal cannabis and consumer products containing cannabinoids. A product name or low THC result does not, by itself, establish that a finished product can lawfully be sold for every purpose.
This is a general information guide, not individual legal or medical advice. Legislation and regulatory sources are linked beside the relevant sections; the reported court case is identified separately.
Personal possession and home cultivation
The following adult personal-use rules concern cannabis controlled under drug law. The separate exclusion for qualifying low-THC CBD flower is explained below. Articles 4A and 7 of Chapter 537 set out the personal-use provisions:
| Situation | General rule |
|---|---|
| Personal possession in public | Up to 7 grams. |
| Dried cannabis at the officially documented residential address | Up to 50 grams for personal use. |
| Home cultivation at that address | Up to four plants per household; not visible to the public or visible or accessible to minors, and without odour nuisance to others. |
| Consumption restrictions | Public consumption, odour nuisance to others and consumption knowingly in the presence of minors remain punishable. |
These provisions do not permit ordinary commercial sale or sharing with others. Cannabis import and export are not authorised by the personal-use rules. See ARUC’s explanation of the framework.
Associations and medicinal cannabis are separate systems
Licensed Cannabis Harm Reduction Associations operate on a non-profit membership basis for eligible adults. They are not public retail shops, and tourists cannot access them as members. ARUC explains these restrictions in its association guidance.
Medicinal cannabis follows a separate regulated framework. Speak to a doctor or pharmacist about assessment, prescription requirements and lawful access. The Malta Medicines Authority publishes the relevant framework and information on approved medicinal cannabis products.
Low-THC CBD flower and the 2025 legal change
Act XII of 2025, article 3, amended the definition of cannabis to expressly exclude qualifying flowers, leaves, extracts and products derived from non-psychoactive phytocannabinoids containing no more than 0.2% psychoactive cannabinoids.
Qualifying low-THC CBD flower can therefore fall outside Malta’s controlled-cannabis rules under an express statutory exception. It should not be described as prohibited simply because it is flower.
The current Dangerous Drugs Ordinance, article 2 and Fifth Schedule, must be read together. The schedule lists CBD, CBG, CBC and CBDV as non-psychoactive phytocannabinoids and THC as a psychoactive cannabinoid. Other cannabinoids should not automatically be treated as having the same classification; separate prohibitions cover scheduled synthetic and semi-synthetic cannabinoids.
What does the recent shop-owner acquittal show?
A court report published on 3 September 2026 describes flower testing between 0.13% and 0.56% THC. According to that report, the material within the statutory limit was excluded from the charges. For the remainder, the acquittal rested on the seller’s reasonable reliance on genuine laboratory certificates and supplier assurances, and the absence of the required criminal intent.
The reported reasoning does not establish a general 0.5% or 0.56% legal limit. A defendant’s criminal liability and the statutory classification of a product are different questions.
Separate requirements for the finished product
The drug-law exclusion is significant, but foods, cosmetics, animal products and other consumer goods also have rules governing their composition, intended use and marketing. A product’s status under one framework does not settle its status under every other framework.
Foods and food supplements
The European Commission’s novel-food status decisions include CBD isolate and CBD extracts. A novel food needs an applicable EU authorisation before it can be marketed as food, subject to that authorisation’s specifications and conditions of use. An application or supplier statement is not an authorisation. See the Commission’s authorisation procedure.
Cosmetics and topical products
A cosmetic must satisfy the EU cosmetics requirements, including an EU responsible person and a product safety report. CPNP is a notification system; notification alone should not be presented as proof that all product requirements have been met. A cosmetic’s documentation does not establish authorisation for oral use.
Products for animals
A “THC-free” label does not establish that a pet product is authorised or suitable for an animal. Animal-feed rules and veterinary-medicine authorisations are separate from human food and cosmetics requirements. Ask for the product’s declared category and supporting documentation, and discuss suitability with a veterinarian.
Product information and supporting documents
Check the stated purpose, ingredients, responsible business, label instructions and any authorisation relevant to the product category. When examining a laboratory report or Certificate of Analysis, check which product and batch it covers, the date and the tests actually performed.
A laboratory result is not a general legal approval, and a report for one batch should not be treated as evidence for every product. Do not assume that a product sold elsewhere in Europe has been assessed for every use or destination.
Travel, delivery and cross-border orders
Before travelling with a cannabinoid product or arranging an overseas order, check the product classification, destination rules and carrier requirements. For prescribed medicines, ask the relevant health authorities about any permits or documentation required. Local possession rules and a retailer’s delivery options do not replace these checks.
About Cannabis Clinics Malta
We are an online retailer and wholesaler serving Malta and Gozo, with wholesale supply across Europe subject to product and destination arrangements. We do not operate as a medical clinic or dispense prescription cannabis.
We have no public walk-in shop. Collection from our Swieqi office is by prior arrangement after readiness and a collection time have been confirmed. Read About Cannabis Clinics Malta and our Shipping Policy for business and delivery information.
Our vape hardware information page covers devices and collection arrangements. Hardware compatibility does not establish the legality or suitability of a cartridge’s contents. For documentation relating to a particular item, contact us with the product name and intended destination.
